Back to Search
Start Over
Supplementary Figure S1 from MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure S1 presents the viability of SW48 and SW48PK cells after treatment with BEZ235 and TAK-228 at the 100-400nM concentrations.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....3797d51c82d44138bbd5766b7be6a207
- Full Text :
- https://doi.org/10.1158/1535-7163.22507717.v1